Dec 2025 $2 M No. 4 $2 to $10 million 2
Goodwin Biotechnology, Inc: Raise no. 4, Dec 2025 × Investors in this round 2 investors had bought by the notice of Jan 27, 2026: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken $1,000,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited Section 4(a)(5): accredited investors only, up to $5 million, no public advertising
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl Pinto · Executive Officer, Director Steven Vorgity · Executive Officer Brandon Price · Director Divya Menezes · Director Kent Payne · Director Nikhil Puri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Karl Pinto, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 27, 2026. Read the notice at the SEC .
debt, options SEC Nov 2024 $3 M No. 3 $2 to $10 million 1
Goodwin Biotechnology, Inc: Raise no. 3, Nov 2024 × Investors in this round 1 investor had bought by the notice of Nov 12, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken $3,000,000
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited Section 4(a)(5): accredited investors only, up to $5 million, no public advertising
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl Pinto · Executive Officer, Director Steven Vorgity · Executive Officer Brandon Price · Director Divya Menezes · Director Kent Payne · Director Nikhil Puri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Karl Pinto, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 12, 2024. Read the notice at the SEC .
debt, options SEC Sep 2023 $5 M No. 2 $2 to $10 million 3
Goodwin Biotechnology, Inc: Raise no. 2, Sep 2023 × Investors in this round 3 investors had bought by the notice of Oct 2, 2023: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $522,500
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited Section 4(a)(5): accredited investors only, up to $5 million, no public advertising
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Darrin Schellin · Executive Officer, Director Steven Vorgity · Executive Officer Brandon Price · Director Divya Menezes · Director Karl Pinto · Director Kent Payne · Director Nikhil Puri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Darrin Schellin, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 2, 2023. Read the notice at the SEC .
equity, options SEC Apr 2019 $21 M No. 1 $10 to $50 million 5
Goodwin Biotechnology, Inc: Raise no. 1, Apr 2019 × Investors in this round 5 investors had bought by the notice of Apr 30, 2019: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $21 M of $21 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $600,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl Pinto · Executive Officer, Director · Chief Executive Officer and President SooYoung S. Lee · Executive Officer · Chief Operating Officer and Secretary Sunil K. Agarwal · Executive Officer · Financial Controller and Treasurer Cesar K. Menezes · Director Divya K. Menezes · Director Jerry Emila Liao · Director Maria Emila Menezes · Director Nikhil Emila Puri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Fairmount Partners LP (CRD 146668) · broker-dealer Cornelius P. McCarthy III (CRD 2153332) · West Conshohocken, Pennsylvania Sold in NY, PA Signed by Sunil K. Agarwal, Financial Controller. Source: SEC Form D, newest notice filed Apr 30, 2019. Read the notice at the SEC .
equity SEC